56 related articles for article (PubMed ID: 7568926)
1. [Recent adenosine antagonists].
Suzuki F; Shimada J
Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1277-92. PubMed ID: 7568926
[No Abstract] [Full Text] [Related]
2. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
[TBL] [Abstract][Full Text] [Related]
3. Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility.
Baraldi PG; Tabrizi MA; Gessi S; Borea PA
Chem Rev; 2008 Jan; 108(1):238-63. PubMed ID: 18181659
[No Abstract] [Full Text] [Related]
4. Effects of substituent size upon adenosine receptor A1/A2 affinity of some newly synthesised 8-cycloalkyl xanthines.
Castagnino E; Salvatori A; Corsano S; Tacchi P; Martini C; Lucacchini A
Drug Des Discov; 1995 Apr; 12(4):313-21. PubMed ID: 9040991
[TBL] [Abstract][Full Text] [Related]
5. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
Yan L; Müller CE
J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
[TBL] [Abstract][Full Text] [Related]
6. Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?
González MP; Terán C; Teijeira M
Med Res Rev; 2008 May; 28(3):329-71. PubMed ID: 17668454
[TBL] [Abstract][Full Text] [Related]
7. Development of spin-labeled probes for adenosine receptors.
Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE
J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine.
Pfister JR; Belardinelli L; Lee G; Lum RT; Milner P; Stanley WC; Linden J; Baker SP; Schreiner G
J Med Chem; 1997 Jun; 40(12):1773-8. PubMed ID: 9191953
[TBL] [Abstract][Full Text] [Related]
9. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
[TBL] [Abstract][Full Text] [Related]
10. De novo analysis of receptor binding affinity data of xanthine adenosine receptor antagonists.
Dalpiaz A; Gardenghi A; Borea PA
Arzneimittelforschung; 1995 Mar; 45(3):230-3. PubMed ID: 7741774
[TBL] [Abstract][Full Text] [Related]
11. Antiparkinsonian activity of adenosine A2A antagonists in experimental models.
Kuwana Y; Shiozaki S; Kanda T; Kurokawa M; Koga K; Ochi M; Ikeda K; Kase H; Jackson MJ; Smith LA; Pearce RK; Jenner PG
Adv Neurol; 1999; 80():121-3. PubMed ID: 10410710
[No Abstract] [Full Text] [Related]
12. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 1-alkyl-8-substituted-3-(3-methoxypropyl) xanthines as putative A(2B) receptor antagonists.
Nieto MI; Balo MC; Brea J; Caamaño O; Cadavid MI; Fernández F; Mera XG; López C; Rodríguez-Borges JE
Bioorg Med Chem; 2009 May; 17(9):3426-32. PubMed ID: 19346133
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)- pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity.
Akahane A; Katayama H; Mitsunaga T; Kato T; Kinoshita T; Kita Y; Kusunoki T; Terai T; Yoshida K; Shiokawa Y
J Med Chem; 1999 Mar; 42(5):779-83. PubMed ID: 10072675
[No Abstract] [Full Text] [Related]
15. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B
J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813
[TBL] [Abstract][Full Text] [Related]
17. CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity.
Gellai M; Schreiner GF; Ruffolo RR; Fletcher T; DeWolf R; Brooks DP
J Pharmacol Exp Ther; 1998 Sep; 286(3):1191-6. PubMed ID: 9732378
[TBL] [Abstract][Full Text] [Related]
18. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
[TBL] [Abstract][Full Text] [Related]
20. 8-(Dicyclopropylmethyl)-1,3-dipropylxanthine: a potent and selective adenosine A1 antagonist with renal protective and diuretic activities.
Shimada J; Suzuki F; Nonaka H; Karasawa A; Mizumoto H; Ohno T; Kubo K; Ishii A
J Med Chem; 1991 Jan; 34(1):466-9. PubMed ID: 1992150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
